Strs Ohio Abbott Laboratories Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Abbott Laboratories stock. As of the latest transaction made, Strs Ohio holds 617,564 shares of ABT stock, worth $71 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

617,564

Previous 624,491 1.11%

Holding current value

$71 Million

Previous $64.9 Million 8.5%

% of portfolio

0.28%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$100.07 - $118.13 $693,184 - $818,286	-6,927 Reduced 1.11%	617,564 $70.4 Million
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $615,460 - $687,008	-6,110 Reduced 0.97%	624,491 $64.9 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $2.27 Million - $2.51 Million	20,744 Added 3.4%	630,601 $71.7 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $2.1 Million - $2.57 Million	-23,324 Reduced 3.68%	609,857 $67.1 Million
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $1.16 Million - $1.4 Million	-12,180 Reduced 1.89%	633,181 $61.3 Million
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $65 Million - $72.5 Million	645,361 New	645,361 $70.4 Million
Q1 2023 Aug 02, 2023	BUY	$96.86 - $114.01 $2.81 Million - $3.31 Million	29,009 Added 4.5%	674,370 $68.3 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $1.99 Million - $2.33 Million	-20,935 Reduced 3.02%	671,536 $73.7 Million
Q3 2022 Oct 27, 2022	SELL	$96.76 - $112.03 $2.3 Million - $2.66 Million	-23,775 Reduced 3.32%	692,471 $67 Million
Q2 2022 Jul 25, 2022	SELL	$102.07 - $123.37 $788,184 - $952,663	-7,722 Reduced 1.07%	716,246 $77.8 Million
Q1 2022 Apr 21, 2022	SELL	$114.02 - $139.04 $770,205 - $939,215	-6,755 Reduced 0.92%	723,968 $85.7 Million
Q4 2021 Jan 24, 2022	SELL	$115.53 - $141.46 $5.91 Million - $7.23 Million	-51,132 Reduced 6.54%	730,723 $103 Million
Q3 2021 Oct 22, 2021	SELL	$116.66 - $129.06 $6.75 Million - $7.46 Million	-57,823 Reduced 6.89%	781,855 $92.4 Million
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $16.7 Million - $19.6 Million	-157,524 Reduced 15.8%	839,678 $97.3 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $41.6 Million - $49 Million	-381,787 Reduced 27.69%	997,202 $120 Million
Q4 2020 Jan 25, 2021	SELL	$105.0 - $114.42 $13.2 Million - $14.4 Million	-125,589 Reduced 8.35%	1,378,989 $151 Million
Q3 2020 Dec 14, 2020	SELL	$91.64 - $111.29 $15.3 Million - $18.5 Million	-166,532 Reduced 9.97%	1,504,578 $164 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $6.7 Million - $8.58 Million	-87,554 Reduced 4.98%	1,671,110 $153 Million
Q1 2020 Apr 23, 2020	BUY	$62.82 - $91.86 $7.08 Million - $10.3 Million	112,628 Added 6.84%	1,758,664 $139 Million
Q4 2019 Jan 24, 2020	SELL	$78.51 - $87.4 $3.87 Million - $4.31 Million	-49,304 Reduced 2.91%	1,646,036 $143 Million
Q3 2019 Oct 21, 2019	BUY	$81.84 - $88.74 $38.9 Million - $42.1 Million	474,836 Added 38.9%	1,695,340 $142 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $9.06 Million - $10.6 Million	124,302 Added 11.34%	1,220,504 $103 Million
Q1 2019 Apr 19, 2019	BUY	$66.22 - $80.06 $44,499 - $53,800	672 Added 0.06%	1,096,202 $87.6 Million
Q4 2018 Jan 23, 2019	BUY	$65.56 - $74.27 $361,760 - $409,821	5,518 Added 0.51%	1,095,530 $79.2 Million
Q3 2018 Oct 19, 2018	SELL	$60.81 - $73.36 $4.53 Million - $5.46 Million	-74,493 Reduced 6.4%	1,090,012 $80 Million
Q2 2018 Aug 06, 2018	SELL	$57.57 - $63.54 $6.43 Million - $7.09 Million	-111,616 Reduced 8.75%	1,164,505 $71 Million
Q1 2018 Apr 20, 2018	SELL	$56.27 - $63.62 $1.73 Million - $1.96 Million	-30,769 Reduced 2.35%	1,276,121 $76.5 Million
Q4 2017 Jan 23, 2018	SELL	$53.68 - $57.47 $2.33 Million - $2.49 Million	-43,390 Reduced 3.21%	1,306,890 $74.6 Million
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $64.9 Million - $72.4 Million	1,350,280	1,350,280 $72.1 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account